Public Employees Retirement Association of Colorado Boosts Position in The Cooper Companies, Inc. (NASDAQ:COO)

Public Employees Retirement Association of Colorado increased its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 1,270.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 61,622 shares of the medical device company’s stock after acquiring an additional 57,126 shares during the period. Public Employees Retirement Association of Colorado owned about 0.12% of Cooper Companies worth $23,320,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also recently made changes to their positions in the company. Cary Street Partners Investment Advisory LLC acquired a new stake in shares of Cooper Companies during the 3rd quarter worth approximately $26,000. Blue Trust Inc. increased its stake in Cooper Companies by 54.8% in the fourth quarter. Blue Trust Inc. now owns 96 shares of the medical device company’s stock valued at $36,000 after purchasing an additional 34 shares during the last quarter. Lindbrook Capital LLC raised its stake in Cooper Companies by 182.5% during the 4th quarter. Lindbrook Capital LLC now owns 113 shares of the medical device company’s stock worth $43,000 after acquiring an additional 73 shares in the last quarter. Loomis Sayles & Co. L P raised its stake in Cooper Companies by 26.5% during the 3rd quarter. Loomis Sayles & Co. L P now owns 167 shares of the medical device company’s stock worth $53,000 after acquiring an additional 35 shares in the last quarter. Finally, Desjardins Global Asset Management Inc. increased its stake in Cooper Companies by 44.8% in the fourth quarter. Desjardins Global Asset Management Inc. now owns 152 shares of the medical device company’s stock valued at $58,000 after purchasing an additional 47 shares during the period. 24.39% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

COO has been the topic of a number of research analyst reports. Stifel Nicolaus reissued a “buy” rating and set a $110.00 price objective (up previously from $105.00) on shares of Cooper Companies in a report on Friday, March 1st. Robert W. Baird boosted their price objective on shares of Cooper Companies from $116.00 to $118.00 and gave the stock an “outperform” rating in a research note on Friday, May 31st. TheStreet downgraded shares of Cooper Companies from a “b-” rating to a “c” rating in a research note on Thursday, February 29th. KeyCorp began coverage on shares of Cooper Companies in a research note on Tuesday, February 6th. They issued a “sector weight” rating for the company. Finally, JPMorgan Chase & Co. upgraded shares of Cooper Companies from a “neutral” rating to an “overweight” rating and increased their price objective for the company from $100.00 to $120.00 in a research note on Wednesday, March 13th. Four analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $111.42.

Cooper Companies Price Performance

Shares of NASDAQ:COO traded down $0.33 during trading hours on Wednesday, hitting $94.23. 845,788 shares of the company’s stock traded hands, compared to its average volume of 1,089,209. The Cooper Companies, Inc. has a 52 week low of $75.93 and a 52 week high of $104.07. The company has a debt-to-equity ratio of 0.34, a quick ratio of 1.14 and a current ratio of 1.95. The company’s fifty day simple moving average is $94.17 and its two-hundred day simple moving average is $93.92. The company has a market cap of $18.76 billion, a price-to-earnings ratio of 55.35, a price-to-earnings-growth ratio of 2.35 and a beta of 1.02.

Cooper Companies (NASDAQ:COO) last announced its earnings results on Thursday, May 30th. The medical device company reported $0.85 EPS for the quarter, topping the consensus estimate of $0.83 by $0.02. Cooper Companies had a net margin of 9.11% and a return on equity of 8.87%. The company had revenue of $942.60 million during the quarter, compared to analysts’ expectations of $948.07 million. During the same period last year, the company posted $0.77 earnings per share. The business’s revenue for the quarter was up 7.4% on a year-over-year basis. As a group, equities analysts anticipate that The Cooper Companies, Inc. will post 3.57 EPS for the current fiscal year.

Insider Transactions at Cooper Companies

In other news, CAO Agostino Ricupati sold 54,724 shares of the stock in a transaction that occurred on Monday, March 18th. The shares were sold at an average price of $100.89, for a total value of $5,521,104.36. Following the completion of the sale, the chief accounting officer now directly owns 5,081 shares of the company’s stock, valued at $512,622.09. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 2.00% of the stock is owned by insiders.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.